Wednesday, May 29 ISRS 2019 Program Schedule

08:30    KEYNOTE LECTURE 4

            Session Chairs: Albert Windhorst

O-44       Engineered antibodies – new possibilities for brain PET.
Stina Syvanen, Uppsala University

09:15    RADIOCHEMISTRY - OTHER RADIONUCLIDES & TARGETRY

            Session Chairs: Cathy Cutler | Jason Holland

O-45       Toward Auger radiotherapy with 103mRh: Bifunctional 16aneS4 chelator synthesis and development of a 103mRh generator
Charlotte Magnus, DTU Nutech, Technical University of Denmark (DTU)

O-46       Synthesis of precursors for 211At-labelling of anti-PSMA HuJ591 mAb and stability comparison after in vitro cellular internalization.
Jean-Francois Gestin, CRCINA INSERM CNRS

O-48       Large scale production and isolation of theranostic radionuclides 76Br and 77Br
Paul Ellison, University of Wisconsin

O-47       Radiosynthesis of a novel 77Br-labeled PARP-1 inhibitor through Cu-mediated aryl boronic ester bromination
Paul Ellison, University of Wisconsin

10:15    COFFEE BREAK 5/29

11:00    RADIOLABELED COMPOUNDS - NEURO SCIENCES SESSION 1

            Session Chairs: Frederick Chin | Hongmei Jia

O-49       Neuroinflammation imaging with the P2X7R PET tracer [11C]SMW139 in the experimental autoimmune encephalomyelitis (EAE) model
Wissam Beaino, Amsterdam UMC, VU University, Radiology and Nuclear medicine, Radionuclide Center, De Boelelaan 1085c, Amsterdam, The Netherlands.

O-50       Fluorinated Benzimidazole Sulfones as Candidate Radioligands for CB2 PET-Imaging
Annukka Kallinen, The University of Sydney

O-51       Synthesis and evaluation in rats of [11C]NR2B-Me as a PET radioligand for NR2B subunits in NMDA receptors
Lisheng Cai, National Institute of Mental Health

O-52       Evaluation of a novel 125I ligand for efficient α-synuclein compound screening
Bieneke Janssen, University of Pennsylvania

O-53       Synthesis of [18F]fluorotetrazines and coupling to trans-cyclooctene functionalized antibodies for amyloid-beta PET
Johanna Rokka, Uppsala University

O-54       Automated routine implementation of [11C]ITDM for a longitudinal evaluation of mGluR1 availability in the Q175DN mouse model for Huntington’s disease
Špela Korat, University of Antwerp

12:30    LUNCH 5/29

14:00    EXCURSION